Standard Chem & Pharm Co Ltd
TWSE:1720
Standard Chem & Pharm Co Ltd
TWSE:1720
Price:
63.2
TWD
-0.16%
Market Closed
Market Cap:
11.3B
TWD
Balance Sheet
Balance Sheet Decomposition
Standard Chem & Pharm Co Ltd
Standard Chem & Pharm Co Ltd
| Current Assets | 4.9B |
| Cash & Short-Term Investments | 1.7B |
| Receivables | 1.4B |
| Other Current Assets | 1.8B |
| Non-Current Assets | 6.3B |
| Long-Term Investments | 1.4B |
| PP&E | 4.4B |
| Intangibles | 208m |
| Other Non-Current Assets | 210.3m |
Balance Sheet
Standard Chem & Pharm Co Ltd
Standard Chem & Pharm Co Ltd
Currency: TWD
Millions
Annual
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
543
|
766
|
877
|
1 193
|
1 254
|
1 472
|
1 036
|
2 564
|
2 259
|
2 037
|
|
| Cash |
348
|
598
|
591
|
727
|
837
|
883
|
646
|
1 060
|
648
|
960
|
|
| Cash Equivalents |
195
|
169
|
286
|
466
|
417
|
588
|
390
|
1 504
|
1 612
|
1 077
|
|
| Short-Term Investments |
180
|
170
|
287
|
213
|
196
|
220
|
445
|
425
|
340
|
239
|
|
| Total Receivables |
894
|
897
|
975
|
937
|
937
|
916
|
967
|
1 490
|
1 480
|
1 419
|
|
| Accounts Receivables |
598
|
599
|
645
|
573
|
678
|
684
|
773
|
881
|
986
|
976
|
|
| Other Receivables |
297
|
298
|
330
|
364
|
259
|
232
|
194
|
609
|
494
|
442
|
|
| Inventory |
750
|
650
|
738
|
728
|
793
|
915
|
894
|
1 218
|
1 386
|
1 615
|
|
| Other Current Assets |
84
|
121
|
81
|
93
|
119
|
91
|
260
|
87
|
124
|
109
|
|
| Total Current Assets |
2 451
|
2 604
|
2 958
|
3 163
|
3 299
|
3 614
|
3 602
|
5 784
|
5 589
|
5 418
|
|
| PP&E Net |
1 996
|
2 218
|
2 183
|
2 235
|
2 207
|
2 388
|
2 447
|
3 095
|
4 109
|
4 359
|
|
| PP&E Gross |
1 996
|
2 218
|
2 183
|
2 235
|
2 207
|
2 388
|
2 447
|
3 095
|
4 109
|
4 359
|
|
| Accumulated Depreciation |
1 479
|
1 453
|
1 610
|
1 781
|
1 916
|
2 077
|
2 221
|
2 566
|
2 748
|
3 023
|
|
| Intangible Assets |
146
|
135
|
120
|
49
|
41
|
26
|
19
|
61
|
51
|
41
|
|
| Goodwill |
0
|
0
|
0
|
70
|
70
|
70
|
70
|
162
|
174
|
174
|
|
| Long-Term Investments |
599
|
644
|
799
|
650
|
586
|
620
|
669
|
769
|
844
|
968
|
|
| Other Long-Term Assets |
182
|
195
|
167
|
207
|
235
|
210
|
242
|
223
|
201
|
229
|
|
| Other Assets |
0
|
0
|
0
|
70
|
70
|
70
|
70
|
162
|
174
|
174
|
|
| Total Assets |
5 375
N/A
|
5 795
+8%
|
6 226
+7%
|
6 374
+2%
|
6 439
+1%
|
6 928
+8%
|
7 049
+2%
|
10 095
+43%
|
10 968
+9%
|
11 189
+2%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
369
|
351
|
417
|
333
|
386
|
422
|
439
|
624
|
686
|
643
|
|
| Short-Term Debt |
171
|
186
|
570
|
720
|
735
|
865
|
566
|
1 358
|
1 350
|
800
|
|
| Current Portion of Long-Term Debt |
28
|
123
|
5
|
30
|
60
|
13
|
18
|
20
|
21
|
83
|
|
| Other Current Liabilities |
486
|
517
|
655
|
563
|
507
|
513
|
629
|
713
|
822
|
845
|
|
| Total Current Liabilities |
1 053
|
1 178
|
1 647
|
1 646
|
1 688
|
1 813
|
1 651
|
2 716
|
2 880
|
2 371
|
|
| Long-Term Debt |
181
|
21
|
47
|
187
|
152
|
144
|
202
|
290
|
419
|
445
|
|
| Deferred Income Tax |
64
|
63
|
62
|
62
|
68
|
62
|
62
|
84
|
85
|
84
|
|
| Minority Interest |
301
|
342
|
477
|
530
|
565
|
882
|
940
|
2 458
|
2 682
|
2 838
|
|
| Other Liabilities |
471
|
647
|
273
|
276
|
285
|
262
|
229
|
206
|
149
|
152
|
|
| Total Liabilities |
2 070
N/A
|
2 251
+9%
|
2 506
+11%
|
2 702
+8%
|
2 758
+2%
|
3 164
+15%
|
3 084
-3%
|
5 753
+87%
|
6 215
+8%
|
5 890
-5%
|
|
| Equity | |||||||||||
| Common Stock |
1 787
|
1 787
|
1 787
|
1 787
|
1 787
|
1 787
|
1 787
|
1 787
|
1 787
|
1 787
|
|
| Retained Earnings |
880
|
1 171
|
1 359
|
1 531
|
1 607
|
1 702
|
1 946
|
2 461
|
2 862
|
3 275
|
|
| Additional Paid In Capital |
424
|
335
|
287
|
197
|
197
|
205
|
203
|
204
|
220
|
224
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
287
|
166
|
99
|
85
|
46
|
89
|
109
|
21
|
|
| Other Equity |
214
|
251
|
1
|
9
|
10
|
15
|
17
|
21
|
6
|
7
|
|
| Total Equity |
3 305
N/A
|
3 545
+7%
|
3 719
+5%
|
3 672
-1%
|
3 681
+0%
|
3 764
+2%
|
3 966
+5%
|
4 342
+9%
|
4 753
+9%
|
5 299
+11%
|
|
| Total Liabilities & Equity |
5 375
N/A
|
5 795
+8%
|
6 226
+7%
|
6 374
+2%
|
6 439
+1%
|
6 928
+8%
|
7 049
+2%
|
10 095
+43%
|
10 968
+9%
|
11 189
+2%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
179
|
179
|
179
|
179
|
179
|
179
|
179
|
179
|
179
|
179
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
